Advanced

Cost of multiple sclerosis in the Czech Republic: The COMS study

Dusankova, J. Blahova ; Kalincik, T. ; Dolezal, T. ; Kobelt, Gisela LU and Havrdova, E. (2012) In Multiple Sclerosis Journal 18(5). p.662-668
Abstract
Background: Information about cost of multiple sclerosis (MS) is available from a number of European countries, but no data from the Czech Republic have been published so far. Objective: The objective of this study was to establish the cost of MS in the Czech Republic, overall and by level of disease severity. Methods: Data on demographics, disease history, resource consumption and production losses were collected from 909 patients recruited in 7 MS centres in the Czech Republic. Annual costs were estimated in the societal perspective, using 2007 unit costs. To evaluate the relationship between disability and costs, patients were stratified into those with mild (67%), moderate (27%) and severe (10%) disability using the Expanded Disability... (More)
Background: Information about cost of multiple sclerosis (MS) is available from a number of European countries, but no data from the Czech Republic have been published so far. Objective: The objective of this study was to establish the cost of MS in the Czech Republic, overall and by level of disease severity. Methods: Data on demographics, disease history, resource consumption and production losses were collected from 909 patients recruited in 7 MS centres in the Czech Republic. Annual costs were estimated in the societal perspective, using 2007 unit costs. To evaluate the relationship between disability and costs, patients were stratified into those with mild (67%), moderate (27%) and severe (10%) disability using the Expanded Disability Status Scale. Results: Mean total annual costs per patient were (sic)12,272, of which 51% were direct medical costs, 4% direct non-medical costs and 45% indirect costs. The average annual costs in patients with mild, moderate and severe disability amounted to (sic)9905, (sic)14,064 and (sic)22,880, respectively. Conclusion: The total costs of MS in the Czech Republic are estimated at (sic)208.6 million per year. Consistent with other studies, the costs increase significantly with the severity of MS. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
cost of illness, Czech Republic, direct costs, disability, indirect, costs, multiple sclerosis
in
Multiple Sclerosis Journal
volume
18
issue
5
pages
662 - 668
publisher
SAGE Publications
external identifiers
  • wos:000303319000106
  • scopus:84860443369
  • pmid:21965424
ISSN
1477-0970
DOI
10.1177/1352458511424422
language
English
LU publication?
yes
id
ad5c1ed9-b114-491e-a17a-6bba19dadfc1 (old id 2551756)
date added to LUP
2016-04-01 11:10:04
date last changed
2020-09-30 01:57:31
@article{ad5c1ed9-b114-491e-a17a-6bba19dadfc1,
  abstract     = {Background: Information about cost of multiple sclerosis (MS) is available from a number of European countries, but no data from the Czech Republic have been published so far. Objective: The objective of this study was to establish the cost of MS in the Czech Republic, overall and by level of disease severity. Methods: Data on demographics, disease history, resource consumption and production losses were collected from 909 patients recruited in 7 MS centres in the Czech Republic. Annual costs were estimated in the societal perspective, using 2007 unit costs. To evaluate the relationship between disability and costs, patients were stratified into those with mild (67%), moderate (27%) and severe (10%) disability using the Expanded Disability Status Scale. Results: Mean total annual costs per patient were (sic)12,272, of which 51% were direct medical costs, 4% direct non-medical costs and 45% indirect costs. The average annual costs in patients with mild, moderate and severe disability amounted to (sic)9905, (sic)14,064 and (sic)22,880, respectively. Conclusion: The total costs of MS in the Czech Republic are estimated at (sic)208.6 million per year. Consistent with other studies, the costs increase significantly with the severity of MS.},
  author       = {Dusankova, J. Blahova and Kalincik, T. and Dolezal, T. and Kobelt, Gisela and Havrdova, E.},
  issn         = {1477-0970},
  language     = {eng},
  number       = {5},
  pages        = {662--668},
  publisher    = {SAGE Publications},
  series       = {Multiple Sclerosis Journal},
  title        = {Cost of multiple sclerosis in the Czech Republic: The COMS study},
  url          = {http://dx.doi.org/10.1177/1352458511424422},
  doi          = {10.1177/1352458511424422},
  volume       = {18},
  year         = {2012},
}